Seminars in Hematology
Volume 43, Issue 1 , Pages 24-31 , January 2006

The Clinical Spectrum of Acute Graft-Versus-Host Disease

  • H. Joachim Deeg

      Affiliations

    • Fred Hutchinson Cancer Research Center, Seattle WA.
    • Corresponding Author InformationAddress correspondence to H. Joachim Deeg, MD, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D1-100, PO Box 19024, Seattle, WA 98109-1024.
    • ,
  • Joseph H. Antin

      Affiliations

    • Dana-Farber Cancer Institute, Boston, MA.

References 

  1. Lorenz E , Uphoff D , Reid TR , et al.   Modification of irradiation injury in mice and guinea pigs by bone marrow injections . J Natl Cancer Inst . 1951;12:197–201
  2. Elkins WL . Cellular immunology and the pathogenesis of graft versus host reactions . Prog Allergy . 1971;15:78–187
  3. van Bekkum DW , de Vries MJ . Radiation Chimaeras . London, UK: Logos Press; 1967;
  4. Billingham RE . In: The Biology of Graft-Versus-Host Reactions, The Harvey Lectures . New York, NY: Academic Press; 1966;p. 21–78
  5. Mathé G , Jammet H , Pendic B , et al.   Transfusions et greffes de moelle osseuse homologue chez des humains irradiés a haute dose accidentellement . Rev Franc Etudes Clin Biol . 1959;4:226–238
  6. Glucksberg H , Storb R , Fefer A , et al.   Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors . Transplantation . 1974;18:295–304
  7. Mielcarek M , Martin PJ , Leisenring W , et al.   Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation . Blood . 2003;102:756–762
  8. Mielcarek M , Burroughs L , Leisenring W , et al.   Prognostic relevance of “early-onset” graft-versus-host disease following nonmyeloablative hematopoietic cell transplantation . Br J Haematol . 2005;129:381–391
  9. Flowers MED , Traina F , Storer B , et al.   Serious graft-versus-host disease after hematopoietic cell transplantation following nonmyeloablative conditioning . Bone Marrow Transplant . 2005;35:277–282
  10. Nash RA , Antin JH , Karanes C , et al.   Phase 3 study comparing methotrexate and tacrolimus with methotrexate and CSP for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors . Blood . 2000;96:2062–2068
  11. Martin P , Nash R , Sanders J , et al.   Reproducibility in retrospective grading of acute graft-versus-host disease after allogeneic marrow transplantation . Bone Marrow Transplant . 1998;21:273–279
  12. Rowlings PA , Przepiorka D , Klein JP , et al.   IBMTR Severity Index for grading acute graft-versus-host disease (Retrospective comparison with Glucksberg grade) . Br J Haematol . 1997;97:855–864
  13. Sullivan KM , Deeg HJ , Sanders J , et al.   Hyperacute graft-v-host disease in patients not given immunosuppression after allogeneic marrow transplantation . Blood . 1986;67:1172–1175
  14. Antin JH , Bierer BE , Smith BR , et al.   Selective depletion of bone marrow T lymphocytes with anti-CD5 monoclonal antibodies (Effective prophylaxis for graft-versus-host disease in patients with hematologic malignancies) . Blood . 1991;78:2139–2149
  15. Antin JH , Ferrara JLM . Cytokine dysregulation and acute graft-versus-host disease . Blood . 1992;80:2964–2968
  16. Spitzer TR . Engraftment syndrome following hematopoietic stem cell transplantation . Bone Marrow Transplant . 2001;27:893–898
  17. Crider MK , Jansen J , Norins AL , et al.   Chemotherapy-induced acral erythema in patients receiving bone marrow transplantation . Arch Dermatol . 1986;122:1023–1027
  18. Akpek G , Boitnott JK , Lee LA , et al.   Hepatitic variant of graft-versus-host disease after donor lymphocyte infusion . Blood . 2002;100:3903–3907
  19. Shulman HM , Gooley T , Dudley MD , et al.   Utility of transvenous liver biopsies and wedged hepatic venous pressure measurements in sixty marrow transplant recipients . Transplantation . 1995;59:1015–1022
  20. Carreras E , Granena A , Navasa M , et al.   Transjugular liver biopsy in BMT . Bone Marrow Transplant . 1993;11:21–26
  21. Weisdorf DJ , Snover DC , Haake R , et al.   Acute upper gastrointestinal graft-versus-host disease (Clinical significance and response to immunosuppressive therapy) . Blood . 1990;76:624–629
  22. Sale GE , Shulman HM , McDonald GB , et al.   Gastrointestinal graft-versus-host disease in man. A clinicopathologic study of the rectal biopsy . Am J Surg Pathol . 1979;3:291–299
  23. Kraus MD , Feran-Doza M , Garcia-Moliner ML , et al.   Cytomegalovirus infection in the colon of bone marrow transplantation patients . Mod Pathol . 1998;11:29–36
  24. Spencer GD , Hackman RC , McDonald GB , et al.   A prospective study of unexplained nausea and vomiting after marrow transplantation . Transplantation . 1986;42:602–607
  25. Wu D , Hockenbery DM , Brentnall TA , et al.   Persistent nausea and anorexia after marrow transplantation (A prospective study of 78 patients) . Transplantation . 1998;66:1319–1324
  26. Klein SA , Martin H , Schreiber-Dietrich D , et al.   A new approach to evaluating intestinal acute graft-versus-host disease by transabdominal sonography and colour Doppler imaging . Br J Haematol . 2001;115:929–934
  27. Mentzel HJ , Kentouche K , Kosmehl H , et al.   US and MRI of gastrointestinal graft-versus-host disease . Pediatr Radiol . 2002;32:195–198
  28. Ho VT , Weller E , Lee SJ , et al.   Prognostic factors for early severe pulmonary complications after hematopoietic stem cell transplantation . Biol Blood Marrow Transplant . 2001;7:223–229
  29. Beschorner WE , Saral R , Hutchins GM , et al.   Lymphocytic bronchitis associated with graft-versus-host disease in recipients of bone-marrow transplants . N Engl J Med . 1978;299:1030–1036
  30. Padovan CS , Bise K , Hahn J , et al.   Angiitis of the central nervous system after allogeneic bone marrow transplantation? . Stroke . 1999;30:1651–1656
  31. Takatsuka H , Okamoto T , Yamada S , et al.   New imaging findings in a patient with central nervous system dysfunction after bone marrow transplantation . Acta Haematol . 2000;103:203–205
  32. Lerner KG , Kao GF , Storb R , et al.   Histopathology of graft-vs.-host reaction (GvHR) in human recipients of marrow from HL-A-matched sibling donors . Transplant Proc . 1974;6:367–371
  33. Kohler S , Hendrickson MR , Chao NJ , et al.   Value of skin biopsies in assessing prognosis and progression of acute graft-versus-host disease . Am J Surg Pathol . 1997;21:988–996
  34. Zhou Y , Barnett MJ , Rivers JK . Clinical significance of skin biopsies in the diagnosis and management of graft-vs-host disease in early postallogeneic bone marrow transplantation . Arch Dermatol . 2000;136:717–721
  35. Massi D , Franchi A , Pimpinelli N , et al.   A reappraisal of the histopathologic criteria for the diagnosis of cutaneous allogeneic acute graft-vs-host disease . Am J Clin Pathol . 1999;112:791–800
  36. Snover DC , Weisdorf SA , Ramsay NK , et al.   Hepatic graft versus host disease (A study of the predictive value of liver biopsy in diagnosis) . Hepatology . 1984;4:123–130
  37. Shulman HM , Sharma P , Amos D , et al.   A coded histologic study of hepatic graft-versus-host disease after human bone marrow transplantation . Hepatology . 1988;8:463–470
  38. Atkinson K , Storb R , Prentice RL , et al.   Analysis of late infections in 89 long-term survivors of bone marrow transplantation . Blood . 1979;53:720–731
  39. Lee CK , Gingrich RD , Hohl RJ , et al.   Engraftment syndrome in autologous bone marrow and peripheral stem cell transplantation . Bone Marrow Transplant . 1995;16:175–182
  40. Ravoet C , Feremans W , Husson B , et al.   Clinical evidence for an engraftment syndrome associated with early and steep neutrophil recovery after autologous blood stem cell transplantation . Bone Marrow Transplant . 1996;18:943–947
  41. Cahill RA , Spitzer TR , Mazumder A . Marrow engraftment and clinical manifestations of capillary leak syndrome . Bone Marrow Transplant . 1996;18:177–184
  42. Anderson BE , McNiff JM , Matte C , et al.   Recipient CD4+ T cells that survive irradiation regulate chronic graft-versus-host disease . Blood . 2004;104:1565–1573
  43. Sviland L , Pearson AD , Eastham EJ , et al.   Histological features of skin and rectal biopsy specimens after autologous and allogeneic bone marrow transplantation . J Clin Pathol . 1988;41:148–154
  44. Gleichmann E , Gleichmann H . Essential similarity between graft-versus-host disease and viral infections . Transplantation . 1976;22:399–401
  45. Gratama JW , Stijnen T , Weiland HT , et al.   Herpes-virus immunity and acute graft-versus-host disease . Lancet . 1987;741–743
  46. Gratama JW , Sinnige LGF , Zwaan FE , et al.   Marrow donor immunity to herpes simplex virus (Association with acute graft-versus-host disease) . Exp Hematol . 1987;15:735–740
  47. Sviland L , Dickinson AM . A human skin explant model for predicting graft-versus-host disease following bone marrow transplantation . J Clin Pathol . 1999;52:910–913
  48. Vogelsang GB , Hess AD , Berkman AW , et al.   An in vitro predictive test for graft versus host disease in patients with genotypic HLA-identical bone marrow transplants . N Engl J Med . 1985;313:645–650
  49. Theobald M , Nierle T , Bunjes D , et al.   Host-specific interleukin-2-secreting donor T-cell precursors as predictors of acute graft-versus-host disease in bone marrow transplantation between HLA-identical siblings . N Engl J Med . 1992;327:1613–1617
  50. Dickinson AM , Sviland L , Wang XN , et al.   Predicting graft-versus-host disease in HLA-identical bone marrow transplant (a comparison of T-cell frequency analysis and a human skin explant model) . Transplantation . 1998;66:857–863
  51. Wang XN , Taylor PR , Skinner R , et al.   T-cell frequency analysis does not predict the incidence of graft-versus-host disease in HLA-matched sibling bone marrow transplantation . Transplantation . 2000;70:488–493
  52. Nichols WC , Antin JH , Lunetta KL , et al.   Polymorphism of adhesion molecule CD31 is not a significant risk factor for graft-versus-host disease . Blood . 1996;88:4429–4434
  53. Dickinson AM , Cavet J , Cullup H , et al.   GvHD risk assessment in hematopoietic stem cell transplantation (Role of cytokine gene polymorphisms and an in vitro human skin explant model) . Hum Immunol . 2001;62:1266–1276
  54. Rocha V , Franco RF , Porcher R , et al.   Host defense and inflammatory gene polymorphisms are associated with outcomes after HLA-identical sibling bone marrow transplantation . Blood . 2002;100:3908–3918
  55. Cullup H , Dickinson AM , Jackson GH , et al.   Donor interleukin 1 receptor antagonist genotype associated with acute graft-versus-host disease in human leucocyte antigen-matched sibling allogeneic transplants . Br J Haematol . 2001;113:807–813
  56. Takahashi H , Furukawa T , Hashimoto S , et al.   Contribution of TNF-alpha and IL-10 gene polymorphisms to graft-versus-host disease following allo-hematopoietic stem cell transplantation . Bone Marrow Transplant . 2000;26:1317–1323
  57. Lin M-T , Storer B , Martin PJ , et al.   Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation . N Engl J Med . 2003;349:2201–2210
  58. Rufer N , Wolpert E , Helg C , et al.   HA-1 and the SMCY-derived peptide FIDSYICQV (H-Y) are immunodominant minor histocompatibility antigens after bone marrow transplantation . Transplantation . 1998;66:910–916
  59. Goulmy E , Schipper J , Pool J , et al.   Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation . N Engl J Med . 1996;334:281–285
  60. Kollman C , Howe CWS , Anasetti C , et al.   Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors (the effect of donor age) . Blood . 2001;98:2043–2051
  61. Tseng L-H , Lin M-T , Hansen JA , et al.   Correlation between disparity for the minor histocompatibility antigen HA-1 and the development of acute graft-versus-host disease after allogeneic marrow transplantation . Blood . 1999;94:2911–2914
  62. Martin PJ . Increased disparity for minor histocompatibility antigens as a potential cause of increased GVHD risk in marrow transplantation from unrelated donors compared with related donors . Bone Marrow Transplant . 1991;8:217–223
  63. Baron F , Baker JE , Storb R , et al.   Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning . Blood . 2004;104:2254–2262
  64. Hagglund H , Bostrom L , Remberger M , et al.   Risk factors for acute graft-versus-host disease in 291 consecutive HLA-identical bone marrow transplant recipients . Bone Marrow Transplant . 1995;16:747–753
  65. Przepiorka D , Smith TL , Folloder J , et al.   Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation . Blood . 1999;94:1465–1470
  66. Nash RA , Pepe MS , Storb R , et al.   Acute graft-versus-host disease (analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate) . Blood . 1992;80:1838–1845
  67. Bross DS , Tutschka PJ , Farmer ER , et al.   Predictive factors for acute graft-versus-host disease in patients transplanted with HLA-identical bone marrow . Blood . 1984;63:1265–1270
  68. Gale RP , Bortin MM , van Bekkum DW , et al.   Risk factors for acute graft-versus-host disease . Br J Haematol . 1987;67:397–406
  69. Weisdorf D , Hakke R , Blazar B , et al.   Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantation . Transplantation . 1991;51:1197–1203
  70. Nakai K , Mineishi S , Kami M , et al.   Antithymocyte globulin affects the occurrence of acute and chronic graft-versus-host disease after a reduced-intensity conditioning regimen by modulating mixed chimerism induction and immune reconstitution . Transplantation . 2003;75:2135–2143
  71. Storb R , Prentice RL , Hansen JA , et al.   Association between HLA-B antigens and acute graft-versus-host disease . Lancet . 1983;2:816–819
  72. Baughan AS , Worsley AM , McCarthy DM , et al.   Haematological reconstitution and severity of graft-versus-host disease after bone marrow transplantation for chronic granulocytic leukaemia (The influence of previous splenectomy) . Br J Haematol . 1984;56:445–454
  73. Bacigalupo A , Van Lint MT , Occhini D , et al.   ABO compatibility and acute graft-versus-host disease following allogeneic bone marrow transplantation . Transplantation . 1988;45:1091–1094
  74. Przepiorka D , Weisdorf D , Martin P , et al.   1994 Consensus conference on acute GVHD grading . Bone Marrow Transplant . 1995;15:825–828
  75. Anasetti C , Doney KC , Storb R , et al.   Marrow transplantation for severe aplastic anemia (Long term outcome in fifty “untransfused” patients) . Ann Intern Med . 1986;104:461–466
  76. Saunders MD , Shulman HM , Murakami CS , et al.   Bile duct apoptosis and cholestasis resembling acute graft-versus-host disease after autologous hematopoietic cell transplantation . Am J Surg Pathol . 2000;24:1004–1008
  77. Hess AD , Bright EC , Thoburn C , et al.   Specificity of effector T lymphocytes in autologous graft-versus-host disease (role of the major histocompatibility complex class II invariant chain peptide) . Blood . 1997;89:2203–2209
  78. Hess AD , Horwitz L , Beschorner WE , et al.   Development of graft-vs.-host disease-like syndrome in cyclosporine-treated rats after syngeneic bone marrow transplantation. I. Development of cytotoxic T lymphocytes with apparent polyclonal anti-Ia specificity, including autoreactivity . J Exp Med . 1985;161:718–730
  79. Nelson JL . Microchimerism (Incidental byproduct of pregnancy or active participant in human health?) . Trends Mol Med . 2002;8:109–113
  80. Adams KM , Holmberg LA , Leisenring W , et al.   Risk factors for syngeneic graft-versus-host disease after adult hematopoietic cell transplantation . Blood . 2004;104:1894–1897
  81. Juji T , Takahashi K , Shibata Y , et al.   Post-transfusion graft-versus-host disease in immunocompetent patients after cardiac surgery in Japan . N Engl J Med . 1989;321:56; (letter)
  82. Greenbaum BH . Transfusion-associated graft-versus-host disease (Historical perspectives, incidence, and current use of irradiated blood products) . J Clin Oncol . 1991;9:1889–1902
  83. Anderson KC , Weinstein HJ . Transfusion-associated graft-versus-host disease . N Engl J Med . 1990;323:315–321

 Supported by Public Health Service Grants No. HL36444, CA18029, and CA15704.

PII: S0037-1963(05)00168-X

doi: 10.1053/j.seminhematol.2005.09.003

Seminars in Hematology
Volume 43, Issue 1 , Pages 24-31 , January 2006

Article Tools